We are delighted to announce the appointment of Barry Davies as Chief Scientific Officer (CSO), to lead the Company’s scientific strategy and Research and Development team. Previously a Senior Director at AstraZeneca, Barry adds significant experience and expertise to our leadership team. His appointment will drive further development of Mosaic’s targeted oncology combination therapies pipeline and platform. Read the full press release here: https://lnkd.in/ejRF3Ws7
Mosaic TX
Biotechnology
Hinxton, Cambridgeshire 1,633 followers
An oncology therapeutics company dedicated to resolving cancer’s complexity to power new treatments for patients.
About us
ABOUT US Mosaic Therapeutics is an oncology therapeutics company using advanced computational methods and next-generation cancer models to discover and develop novel targeted therapies. The company’s main mission is to tackle cancers with substantial unmet need by reinventing the traditional approach to target and drug discovery. Born out of pioneering research at the Wellcome Sanger Institute in collaboration with the Netherlands Cancer Institute, and anchored around a proprietary platform that has seen 20 years of fine-tuning and development, Mosaic has active programmes across a variety of oncology indications and disease biology pathways.
- Website
-
http://www.mosaic-tx.com
External link for Mosaic TX
- Industry
- Biotechnology
- Company size
- 11-50 employees
- Headquarters
- Hinxton, Cambridgeshire
- Type
- Privately Held
- Founded
- 2020
- Specialties
- oncology, therapeutics, cancer medicines, tumour agnostic therapies, AI, genomics, and organoids
Locations
-
Primary
Get directions
BioData Innovation Centre
Wellcome Genome Campus
Hinxton, Cambridgeshire CB10 1DR, GB
Employees at Mosaic TX
-
Magdalena Jonikas
Partner at Syncona Limited
-
Amy Emery
Head of Biology at Mosaic Therapeutics
-
Kirsten McLay
Senior Laboratory Operations Manager at Mosaic TX
-
Joachim Nwezeobi, PhD
Bioinformatician | Data Scientist | Python & R | Statistical & Evolutionary genetics | Insecticide resistance